Amring Pharmaceuticals Inc. acquires six ANDA’s

March 1, 2017 Amring Pharmaceuticals Inc. acquired six ANDA’s from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc.  The acquired ANDAs include niche otic and ophthalmic...